These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11902805)

  • 1. Hyperhomocysteinaemia and cardiovascular risk in female ovariectomized rats: role of folic acid and hormone replacement therapy.
    el-Swefy SE; Ali SI; Asker ME; Mohamed HE
    J Pharm Pharmacol; 2002 Mar; 54(3):391-7. PubMed ID: 11902805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel concept to preserve the beneficial effects of hormone replacement therapy in bilaterally female ovariectomized rats: role of lovastatin therapy.
    El-Swefy SE; Asker ME; Ali SI; Mohammed HE
    Pharmacol Res; 2002 Mar; 45(3):167-73. PubMed ID: 11884211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients.
    van Guldener C; Janssen MJ; de Meer K; Donker AJ; Stehouwer CD
    J Intern Med; 1999 Feb; 245(2):175-83. PubMed ID: 10081520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of postmenopausal hormone therapy with or without folic acid supplementation on serum homocysteine level.
    Toprak A; Erenus M; Ilhan AH; Haklar G; Fak AS; Oktay A
    Climacteric; 2005 Sep; 8(3):279-86. PubMed ID: 16390760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma homocysteine levels in renal transplanted patients on cyclosporine or tacrolimus therapy: effect of treatment with folic acid.
    Fernández-Miranda C; Gómez P; Díaz-Rubio P; Estenoz J; Carillo JL; Andrés A; Morales JM
    Clin Transplant; 2000 Apr; 14(2):110-4. PubMed ID: 10770414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of antioxidant adjuvant treatment with hormone replacement therapy against cardiovascular diseases in ovariectomized rats.
    Shehata M; Kamel MA
    Endocr Regul; 2008 Jun; 42(2-3):69-75. PubMed ID: 18624609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12.
    Ducloux D; Aboubakr A; Motte G; Toubin G; Fournier V; Chalopin JM; Drüeke T; Massy ZA
    Nephrol Dial Transplant; 2002 May; 17(5):865-70. PubMed ID: 11981075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in the lipid profile of patients with chronic renal failure, treated with folic acid.
    de Gómez Dumm NT; Giammona AM; Touceda LA
    Int J Vitam Nutr Res; 2003 May; 73(3):215-20. PubMed ID: 12847999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects.
    Holven KB; Holm T; Aukrust P; Christensen B; Kjekshus J; Andreassen AK; Gullestad L; Hagve TA; Svilaas A; Ose L; Nenseter MS
    Am J Med; 2001 May; 110(7):536-42. PubMed ID: 11343667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.
    Billion S; Tribout B; Cadet E; Queinnec C; Rochette J; Wheatley P; Bataille P
    Nephrol Dial Transplant; 2002 Mar; 17(3):455-61. PubMed ID: 11865092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinemia and oxidative stress in hemodialysis: effects of supplementation with folic acid.
    Chiarello PG; Vannucchi MT; Moysés Neto M; Vannucchi H
    Int J Vitam Nutr Res; 2003 Nov; 73(6):431-8. PubMed ID: 14743547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
    J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with different doses of folic acid in haemodialysis patients: effects on folate distribution and aminothiol concentrations.
    Arnadottir M; Gudnason V; Hultberg B
    Nephrol Dial Transplant; 2000 Apr; 15(4):524-8. PubMed ID: 10727548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of hyperhomocysteinaemia in patients with thrombophilia.
    O'Donnell J; Perry DJ
    Expert Opin Pharmacother; 2002 Nov; 3(11):1591-8. PubMed ID: 12437493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification.
    Selhub J; Jacques PF; Bostom AG; Wilson PW; Rosenberg IH
    Public Health Rev; 2000; 28(1-4):117-45. PubMed ID: 11411265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of folic acid on plasma homocysteine levels & arterial endothelial function in patients with unstable angina.
    Guo H; Chi J; Xing Y; Wang P
    Indian J Med Res; 2009 Mar; 129(3):279-84. PubMed ID: 19491420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hyperhomocysteinemia in children on dialysis by folic acid.
    Schröder CH; de Boer AW; Giesen AM; Monnens LA; Blom H
    Pediatr Nephrol; 1999 Sep; 13(7):583-5. PubMed ID: 10460506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis.
    Achour O; Elmtaoua S; Zellama D; Omezzine A; Moussa A; Rejeb J; Boumaiza I; Bouacida L; Rejeb NB; Achour A; Bouslama A
    J Nephrol; 2016 Oct; 29(5):691-8. PubMed ID: 26559681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinaemia & folic acid supplementation in patients with high risk of coronary artery disease.
    Guo H; Lee JD; Ueda T; Cheng J; Shan J; Wang J
    Indian J Med Res; 2004 Jan; 119(1):33-7. PubMed ID: 14997992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.